Immix Biopharma, Inc. (IMMX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 130.77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -130.77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 10.68M | 10.89M | 7.66M | 6.72M | 4.68M | 4.99M | 7.39M | 4.7M | 5.59M | 5.38M | 4.52M | 3.72M | 2.52M | 3.79M | 1.53M | 1.56M | 1.33M | 598.34K | 347.99K | 243.16K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.82M | 5.17M | 3.08M | 2.75M | 2.71M | 3.61M | 2.95M | 2.48M | 2.34M | 2.28M | 2.42M | 1.51M | 1.2M | 1.53M | 837.44K | 953.2K | 700.51K | 589.1K | 318.3K | 180.4K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 5.98M | 5.73M | 4.58M | 3.97M | 1.98M | 1.37M | 4.45M | 2.22M | 3.25M | 3.1M | 2.11M | 2.21M | 1.32M | 2.26M | 695.94K | 607.75K | 629.53K | 9.24K | 29.69K | 62.76K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -125.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.81M | -10.89M | -7.66M | -6.72M | -4.68M | -4.99M | -7.39M | -4.7M | -5.59M | -5.38M | -4.52M | -3.72M | -2.52M | -3.79M | -1.53M | -1.56M | -1.33M | -598.34K | -347.99K | -243.16K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -130.81% | -118.43% | -3.62% | -42.85% | 16.23% | 7.23% | -63.47% | -26.39% | -121.76% | -41.67% | -195.02% | -138.36% | -89.53% | -534.19% | -340.64% | -541.93% | -718.38% | -289.57% | - | - |
| EBITDA | -10.68M | -10.8M | -7.57M | -6.64M | -4.62M | -4.95M | -7.37M | -4.68M | -5.57M | -5.37M | -4.52M | -3.72M | -2.52M | -3.79M | -1.53M | -1.56M | -1.33M | -597.72K | -347.37K | -242.54K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -130.94% | -118.42% | -2.67% | -41.89% | 16.93% | 7.95% | -62.94% | -25.75% | -120.86% | -41.61% | -195.04% | -138.39% | -89.58% | -534.75% | -341.26% | -543.41% | -721.07% | -290.64% | - | - |
| D&A (Non-Cash Add-back) | 130.77K | 90.63K | 96.99K | 79.83K | 59.18K | 41.34K | 25.91K | 24.3K | 23.85K | 3.08K | 1.38K | 506 | 505 | 566 | 566 | 383 | 620 | 620 | 620 | 620 |
| EBIT | -10.81M | -10.89M | -7.58M | -6.72M | -4.68M | -4.99M | -7.39M | -4.7M | -5.59M | -5.15M | -4.52M | -3.72M | -2.52M | -3.79M | -1.53M | -1.56M | -1.33M | -22.71M | -347.99K | -153.16K |
| Net Interest Income | 717.17K | 216.71K | 84.54K | 104.06K | 150.22K | 185.85K | 256.68K | 306.92K | 267.91K | 228.57K | 186.69K | 128.85K | 27.89K | 0 | 0 | -109 | -388 | -44.51K | -53.94K | -53.87K |
| Interest Income | 717.17K | 216.71K | 84.54K | 104.06K | 150.22K | 185.85K | 256.68K | 306.92K | 267.91K | 228.57K | 186.69K | 128.85K | 27.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109 | 388 | 44.51K | 53.94K | 53.87K |
| Other Income/Expense | 722.17K | 216.71K | 84.54K | 104.06K | 150.22K | 185.85K | 256.68K | 306.92K | 267.91K | 228.57K | 186.69K | 128.85K | 27.89K | 0 | 0 | -109 | -388 | -22.16M | -53.94K | 36.13K |
| Pretax Income | -10.09M | -10.68M | -7.58M | -6.61M | -4.53M | -4.8M | -7.14M | -4.4M | -5.32M | -5.15M | -4.34M | -3.59M | -2.49M | -3.79M | -1.53M | -1.56M | -1.33M | -22.75M | -401.93K | -207.03K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 11.27K | 7.72K | 8.91K | 9.82K | 10.79K | 11.14K | 10.27K | 8.84K | 8.09K | 6.81K | 6.35K | 5.17K | 5.26K | 1.67K | 1.72K | 1.62K | 1.48K | 1.34K | 1.61K |
| Effective Tax Rate % | 0% | -0.11% | -0.1% | -0.13% | -0.22% | -0.22% | -0.16% | -0.23% | -0.17% | -0.16% | -0.16% | -0.18% | -0.21% | -0.14% | -0.11% | -0.11% | -0.12% | -0.01% | -0.33% | -0.78% |
| Net Income | -10.09M | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M | -4.39M | -5.26M | -5.09M | -4.28M | -3.58M | -2.48M | -3.8M | -1.54M | -1.56M | -1.33M | -22.76M | -403.26K | -208.64K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -122.05% | -122.11% | -6.1% | -50.75% | 13.62% | 5.45% | -67.02% | -22.84% | -112.08% | -33.94% | -178.86% | -128.84% | -86.15% | 83.3% | -280.66% | -649.04% | -31.02% | -2872.31% | - | - |
| Net Income (Continuing) | -10.09M | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M | -4.41M | -5.33M | -5.16M | -4.34M | -3.6M | -2.5M | -3.8M | -1.54M | -1.56M | -1.33M | -22.76M | -403.26K | -208.64K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -283.28K | -201.74K | -124.67K | -56.77K | -32.36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.17 | -0.24 | -0.15 | -0.22 | -0.26 | -0.23 | -0.24 | -0.18 | -0.29 | -0.11 | -0.11 | -0.10 | -3.00 | -0.06 | -0.02 |
| EPS Growth % | -20% | -64.71% | 0% | -46.67% | 31.82% | 34.62% | -4.35% | 37.5% | -22.22% | 10.34% | -109.09% | -118.18% | -86.92% | 90.33% | -96.43% | -362.18% | 19.75% | -2900% | - | - |
| EPS (Basic) | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.17 | -0.24 | -0.15 | -0.22 | -0.26 | -0.23 | -0.24 | -0.18 | -0.29 | -0.11 | -0.11 | -0.10 | -3.00 | -0.06 | -0.02 |
| Diluted Shares Outstanding | 38.29M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M |
| Basic Shares Outstanding | 38.29M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |